Arrowhead Pharmaceuticals, Inc.
2020 Q2 - 2025 Q4 (23 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/3/2026 | 417 | 0.0% | 6,155 | 12/31/2025 |
| 2025 Q3 | 11/12/2025 | 508 | 0.0% | 14,731 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 232 | 0.0% | 14,702 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 184 | 0.0% | 14,476 | 3/31/2025 |
| 2024 Q4 | 2/12/2025 | 263 | 0.0% | 13,281 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 208 | 0.0% | 10,725 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 305 | 0.0% | 11,718 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 239 | 0.0% | 8,341 | 3/31/2024 |
| 2023 Q4 | 2/8/2024 | 279 | 0.0% | 8,714 | 12/31/2023 |
| 2023 Q3 | 11/7/2023 | 209 | 0.0% | 7,762 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 269 | 0.0% | 7,552 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 219 | 0.0% | 8,637 | 3/31/2023 |
| 2022 Q4 | 2/7/2023 | 333 | 0.0% | 8,637 | 12/31/2022 |
| 2022 Q3 | 11/1/2022 | 233 | 0.0% | 7,053 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 250 | 0.0% | 7,088 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 199 | 0.0% | 4,319 | 3/31/2022 |
| 2021 Q4 | 2/7/2022 | 284 | 0.0% | 4,065 | 12/31/2021 |
| 2021 Q3 | 11/4/2021 | 270 | 0.0% | 4,328 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 358 | 0.0% | 4,328 | 6/30/2021 |
| 2021 Q1 | 5/6/2021 | 357 | 0.0% | 5,388 | 3/31/2021 |
| 2020 Q4 | 2/9/2021 | 271 | 0.0% | 3,532 | 12/31/2020 |
| 2020 Q3 | 11/10/2020 | 227 | 0.0% | 5,283 | 9/30/2020 |
| 2020 Q2 | 8/6/2020 | 225 | 0.0% | 5,207 | 6/30/2020 |